About
Diagnostics
Areas of Focus
Categories
DiagnosticsNJ, NY, PA
Team (26)
Amitabh Chak, MD
Lucid Diagnostics
team_member
Arvind J. Trindade, MDÂ
VP GI Clinical Operations, Professor of Medicine
Lucid Diagnostics
executive
Brian deGuzman, MD
Chief Technology & Compliance Officer
Lucid Diagnostics
executive
Debbie White
Lucid Diagnostics
team_member
Deepika A. Lakhani, PhD
Senior Vice President
Lucid Diagnostics
executive
Dennis Matheis
Lucid Diagnostics
team_member
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
5
As Collaborator
2
Total Enrollment
1,815
By Phase
NA: 5
By Status
COMPLETED: 4UNKNOWN: 2RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06532734Collaborator
Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype
N/ARecruiting
25 participants
Started: Nov 12, 2024 · Completed: Jan 31, 2026
NCT05778851Lead Sponsor
Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett's Esophagus in At Risk Population
NACompleted
97 participants
Started: Apr 12, 2023 · Completed: Aug 19, 2024
NCT05965999Lead Sponsor
Lucid Registry Study
N/AUnknown
500 participants
Started: Apr 11, 2023 · Completed: Jun 1, 2024
NCT06030180Lead Sponsor
CLUE: CLinical Utility Study of EsoGuard
NACompleted
566 participants
Started: Feb 23, 2023 · Completed: Dec 13, 2024
NCT04311970Collaborator
Pilot Study of Esocheck in Eosinophilic Esophagitis
NACompleted
12 participants
Started: Aug 5, 2020 · Completed: Aug 23, 2021
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...